Cost-Effectiveness of Empagliflozin (Jardiance®) In The Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) In Turkey Based Empa-Reg Outcome Data
Abstract
Authors
E Oksuz S Malhan E Kamaci B Urganci E Tetik A Temizhan R Ersoy Y Balbay